MENU
FATE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fate Therapeutics (FATE) Ownership - Who owns Fate Therapeutics?
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
157.01M
P/E Ratio
N/A
Total Cash
279.07M
Projected Growth
N/A
Total Debt
85.27M
Revenue
13.63M
Risk (Beta)
2.45
Dividend Yield
N/A
Total Cash/Share
2.44
Total Debt/Equity
2.75
Revenue/Share
0.12 USD as % of share price
Fundamentals
FATE
Capitalization
157M
P/E Ratio
N/A
Risk (Beta)
2.45
Dividend Yield
N/A
Total Cash
279M
Total Cash/Share
2.44
Total Debt
85.3M
Total Debt/Equity
2.75
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.12%
Revenue
13.6M
ROE
N/A
Book Value
319M
P/B Ratio
0.49
Cash Flow
N/A
Earnings
-1.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
114K
Current Ratio
7.58
Current Revenue Per Employee
10276.24
Dividends Per Share - Security
N/A
EBITDA
-176.58M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-39.34
Shares Held By Institutions
241M
Shares Outstanding - Current
115M
Total Liabilities
122M
Total Volume MTD
N/A
Value
1
Gain YTD
-19.091
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com